Literature DB >> 21565523

Non-FcεR bearing mast cells secrete sufficient interleukin-4 to control Francisella tularensis replication within macrophages.

Prea Thathiah1, Shilpa Sanapala, Annette R Rodriguez, Jieh-Juen Yu, Ashlesh K Murthy, M Neal Guentzel, Thomas G Forsthuber, James P Chambers, Bernard P Arulanandam.   

Abstract

Mast cells have classically been implicated in the triggering of allergic and anaphylactic reactions. However, recent findings have elucidated the ability of these cells to selectively release a variety of cytokines leading to bacterial clearance through neutrophil and dendritic cell mobilization, and suggest an important role in innate host defenses. Our laboratory has established a primary bone marrow derived mast cell-macrophage co-culture system and found that mast cells mediated a significant inhibition of Francisella tularensis live vaccine strain (LVS) uptake and replication within macrophages through contact and the secreted product interleukin-4 (IL-4). In this study, we utilized P815 mast cells and J774 macrophages to further investigate whether mast cell activation by non-FcεR driven signals could produce IL-4 and control intramacrophage LVS replication. P815 supernatants collected upon activation by the mast cell activating peptide MP7, as well as P815 cells co-cultured with J774 macrophages, exhibited marked inhibition of bacterial uptake and replication, which correlated with the production of IL-4. The inhibition noted in vitro was titratable and preserved at ratios relevant to cellular infiltration events following pulmonary challenge. Collectively, our data suggest that both primary mast cell and P815 mast cell (lacking FcεR) secreted IL-4 can control intramacrophage Francisella replication.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565523      PMCID: PMC3155945          DOI: 10.1016/j.cyto.2011.04.009

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  52 in total

1.  Tularemia vaccine study. II. Respiratory challenge.

Authors:  S SASLAW; H T EIGELSBACH; J A PRIOR; H E WILSON; S CARHART
Journal:  Arch Intern Med       Date:  1961-05

Review 2.  Mast cell-mediated inflammation in asthma.

Authors:  S I Wasserman
Journal:  Ann Allergy       Date:  1989-12

3.  Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.

Authors:  P H Hart; G F Vitti; D R Burgess; G A Whitty; D S Piccoli; J A Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 4.  Recent advances in the cellular and molecular biology of mast cells.

Authors:  R L Stevens; K F Austen
Journal:  Immunol Today       Date:  1989-11

Review 5.  Interleukin 4/B cell stimulatory factor 1: one lymphokine, many functions.

Authors:  W E Paul
Journal:  FASEB J       Date:  1987-12       Impact factor: 5.191

6.  An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells.

Authors:  Igor Golovliov; Vladimir Baranov; Zuzana Krocova; Hana Kovarova; Anders Sjöstedt
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

7.  Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages.

Authors:  Daniel L Clemens; Bai-Yu Lee; Marcus A Horwitz
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 8.  Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.

Authors:  Karen L Elkins; Siobhán C Cowley; Catharine M Bosio
Journal:  Microbes Infect       Date:  2003-02       Impact factor: 2.700

9.  Mutations of Francisella novicida that alter the mechanism of its phagocytosis by murine macrophages.

Authors:  Xin-He Lai; Renee L Shirley; Lidia Crosa; Duangjit Kanistanon; Rebecca Tempel; Robert K Ernst; Larry A Gallagher; Colin Manoil; Fred Heffron
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

10.  Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  J Exp Med       Date:  2003-07-28       Impact factor: 14.307

View more
  3 in total

1.  Sinomenine potentiates P815 cell degranulation via upregulation of Ca2+ mobilization through the Lyn/PLCγ/IP3R pathway.

Authors:  Nan Wang; Rui Liu; Yanping Liu; Ruirui Zhang; Langchong He
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-29       Impact factor: 3.219

2.  Comparison of bone marrow-derived and mucosal mast cells in controlling intramacrophage Francisella tularensis replication.

Authors:  Colleen Hunter; Annette Rodriguez; Jieh-Juen Yu; James Chambers; M Neal Guentzel; Bernard Arulanandam
Journal:  Exp Biol Med (Maywood)       Date:  2012-06-11

3.  Francisella tularensis type B ΔdsbA mutant protects against type A strain and induces strong inflammatory cytokine and Th1-like antibody response in vivo.

Authors:  Adela Straskova; Petra Spidlova; Sherry Mou; Patricia Worsham; Daniela Putzova; Ivona Pavkova; Jiri Stulik
Journal:  Pathog Dis       Date:  2015-08-06       Impact factor: 3.166

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.